Cover Image
市場調查報告書

查加斯氏病(美洲錐蟲病):全球臨床實驗檢討

Chagas Cardiomyopathy Global Clinical Trials Review, H2, 2014

出版商 GlobalData 商品編碼 242625
出版日期 內容資訊 英文 60 Pages
訂單完成後即時交付
價格
Back to Top
查加斯氏病(美洲錐蟲病):全球臨床實驗檢討 Chagas Cardiomyopathy Global Clinical Trials Review, H2, 2014
出版日期: 2014年08月20日 內容資訊: 英文 60 Pages
簡介

本報告提供全球查加斯氏病(美洲錐蟲病)治療藥物臨床實驗相關調查,各地區臨床實驗數資料,實驗階段,實驗狀況,採用主題及各類型贊助企業的臨床實驗資料,中斷(暫時停止,廢止,停止)的實驗清單等資料,為您概述為以下內容。

目錄

  • 表格一覽
  • 圖表一覽
  • 簡介
  • 查加斯氏病(美洲錐蟲病)
  • 報告指南
  • 臨床實驗 , 各地區
  • 臨床實驗 , 各國
  • 對臨床實驗有所貢獻的主要國家 - 亞太地區
  • - 歐洲對臨床實驗有所貢獻的主要5個國家
  • 對臨床實驗有所貢獻的主要國家 - 北美
  • 對臨床實驗有所貢獻的主要國家 - 中南美
  • 臨床實驗 金磚四國 各國
  • 臨床實驗 G7 各國
  • 臨床實驗 - G7 各國 , 各臨床實驗狀態
  • 臨床實驗 E7 各國
  • 臨床實驗 - E7 各國 , 各臨床實驗狀態
  • 各階段臨床實驗
  • 進行中的臨床實驗 各階段
  • 臨床實驗 , 各臨床實驗狀態
  • 未完成的臨床實驗; 查加斯氏病(美洲錐蟲病)
  • 每段時期的實驗人數
  • 有力的贊助商
  • 潛力治療藥物比較
  • 臨床實驗簡介
  • 臨床實驗概要; 主要企業
  • Bayer AG
  • 臨床實驗概要; Bayer AG
  • 臨床實驗概要; 最高級大學 / 研究機關 / 醫院
  • University Medical Center Goettingen
  • 臨床實驗概要; University Medical Center Goettingen
  • The Institute ; Cardiology (IC)
  • 臨床實驗概要; Institute ; Cardiology (IC)
  • Federal University ofMinas Gerais
  • 臨床實驗概要; Federal University ofMinas Gerais
  • 東北大學
  • 臨床實驗概要; 東北大學
  • Mayo Clinic
  • 臨床實驗概要; Mayo Clinic
  • The University ofTexas Southwestern Medical Center at Dallas
  • 臨床實驗概要; University ofTexas Southwestern Medical Center at Dallas
  • The Cleveland Clinic
  • 臨床實驗概要; Cleveland Clinic
  • Virginia Commonwealth University
  • 臨床實驗概要; Virginia Commonwealth University
  • VU University Medical Center
  • 臨床實驗概要; VU University Medical Center
  • University o fCalifornia, Los Angeles
  • 臨床實驗概要; University o fCalifornia, Los Angeles
  • Medical University ofSilesia
  • 臨床實驗概要; Medical University ofSilesia
  • The Hospital for Sick Children
  • 臨床實驗概要; Hospital for Sick Children
  • University ofMichigan
  • 臨床實驗概要; University ofMichigan
  • Charles University
  • 臨床實驗概要; Charles University
  • University ofCalgary
  • 臨床實驗概要; University ofCalgary
  • Johann Wolfgang Goethe University Hospitals
  • 臨床實驗概要; Johann Wolfgang Goethe University Hospitals
  • Massachusetts General Hospital
  • 臨床實驗概要; Massachusetts General Hospital
  • Johns Hopkins University
  • 臨床實驗概要; Johns Hopkins University
  • Assistance Publique - Hopitaux de Paris
  • 臨床實驗概要; Assistance Publique - Hopitaux de Paris
  • University o fCalifornia, Irvine
  • 臨床實驗概要; University o fCalifornia, Irvine
  • Five 主要 臨床簡介

附錄

  • 簡稱
  • 定義
  • 調查方法
  • 二級研究
  • About GlobalData
  • 諮詢方式
  • 免責聲明
  • 資訊來源

表格一覽

表格一覽

  • 查加斯氏病(美洲錐蟲病) 治療藥物市場, 全球市場, 臨床實驗 各地區
  • 查加斯氏病(美洲錐蟲病) 治療藥物市場, 全球市場, 臨床實驗 , 各國排名
  • 查加斯氏病(美洲錐蟲病) 治療藥物市場, 全球市場, 進行中的臨床實驗 , 各國排名
  • 查加斯氏病(美洲錐蟲病) 治療藥物的臨床實驗, 亞太地區, 主要國家
  • 查加斯氏病(美洲錐蟲病) 治療藥物的臨床實驗, 歐洲, 主要5個國家
  • 查加斯氏病(美洲錐蟲病) 治療藥物的臨床實驗, 北美, 主要國家
  • 查加斯氏病(美洲錐蟲病) 治療藥物的臨床實驗, 中南美, 主要國家
  • 查加斯氏病(美洲錐蟲病) 治療藥物的臨床實驗, 金磚四國 各國
  • 查加斯氏病(美洲錐蟲病) 治療藥物的臨床實驗, G7 各國
  • 查加斯氏病(美洲錐蟲病) 治療藥物市場, G7 各國, 臨床實驗 , 各臨床實驗狀態
  • 查加斯氏病(美洲錐蟲病) 治療藥物的臨床實驗, E7 各國
  • 查加斯氏病(美洲錐蟲病) 治療藥物市場, E7 各國, 臨床實驗 , 各臨床實驗狀態
  • 查加斯氏病(美洲錐蟲病) 治療藥物市場, 全球市場, 各階段臨床實驗
  • 查加斯氏病(美洲錐蟲病) 治療藥物市場, 全球市場, 進行中的臨床實驗 各階段
  • 查加斯氏病(美洲錐蟲病) 治療藥物市場, 全球市場, 臨床實驗 , 各臨床實驗狀態
  • 查加斯氏病(美洲錐蟲病) 治療藥物市場, 全球市場, 終止的臨床實驗
  • 查加斯氏病(美洲錐蟲病) 治療藥物的臨床實驗, 全球市場, 平均登計對象人數趨勢
  • 查加斯氏病(美洲錐蟲病) 治療藥物的臨床實驗, 全球市場, 主要的贊助商
  • 查加斯氏病(美洲錐蟲病) 治療藥物的臨床實驗, 全球市場, 臨床實驗, 各有潛力治療藥
  • 查加斯氏病(美洲錐蟲病) 治療藥物的臨床實驗市場, 全球市場, 臨床實驗-Bayer AG
  • 查加斯氏病(美洲錐蟲病) 治療藥物的臨床實驗市場, 全球市場, 臨床實驗-University Medical Center Goettingen
  • 查加斯氏病(美洲錐蟲病) 治療藥物的臨床實驗市場, 全球市場, 臨床實驗-The Institute ; Cardiology (IC)
  • 查加斯氏病(美洲錐蟲病) 治療藥物的臨床實驗市場, 全球市場, 臨床實驗-Federal University ofMinas Gerais
  • 查加斯氏病(美洲錐蟲病) 治療藥物的臨床實驗市場, 全球市場, 臨床實驗-東北大學
  • 查加斯氏病(美洲錐蟲病) 治療藥物的臨床實驗市場, 全球市場, 臨床實驗-Mayo Clinic
  • 查加斯氏病(美洲錐蟲病) 治療藥物的臨床實驗市場, 全球市場, 臨床實驗-The University ofTexas Southwestern Medical Center at Dallas
  • 查加斯氏病(美洲錐蟲病) 治療藥物的臨床實驗市場, 全球市場, 臨床實驗-The Cleveland Clinic
  • 查加斯氏病(美洲錐蟲病) 治療藥物的臨床實驗市場, 全球市場, 臨床實驗-Virginia Commonwealth University
  • 查加斯氏病(美洲錐蟲病) 治療藥物的臨床實驗市場, 全球市場, 臨床實驗-VU University Medical Center
  • 查加斯氏病(美洲錐蟲病) 治療藥物的臨床實驗市場, 全球市場, 臨床實驗-University o fCalifornia, Los Angeles
  • 查加斯氏病(美洲錐蟲病) 治療藥物的臨床實驗市場, 全球市場, 臨床實驗-Medical University ofSilesia
  • 查加斯氏病(美洲錐蟲病) 治療藥物的臨床實驗市場, 全球市場, 臨床實驗-The Hospital for Sick Children
  • 查加斯氏病(美洲錐蟲病) 治療藥物的臨床實驗市場, 全球市場, 臨床實驗-University ofMichigan
  • 查加斯氏病(美洲錐蟲病) 治療藥物的臨床實驗市場, 全球市場, 臨床實驗-Charles University
  • 查加斯氏病(美洲錐蟲病) 治療藥物的臨床實驗市場, 全球市場, 臨床實驗-University ofCalgary
  • 查加斯氏病(美洲錐蟲病) 治療藥物的臨床實驗市場, 全球市場, 臨床實驗-Johann Wolfgang Goethe University Hospitals
  • 查加斯氏病(美洲錐蟲病) 治療藥物的臨床實驗市場, 全球市場, 臨床實驗-Massachusetts General Hospital
  • 查加斯氏病(美洲錐蟲病) 治療藥物的臨床實驗市場, 全球市場, 臨床實驗-Johns Hopkins University
  • 查加斯氏病(美洲錐蟲病) 治療藥物的臨床實驗市場, 全球市場, 臨床實驗-Assistance Publique - Hopitaux de Paris
  • 查加斯氏病(美洲錐蟲病) 治療藥物的臨床實驗市場, 全球市場, 臨床實驗-University o fCalifornia, Irvine

圖表一覽

圖表一覽

  • 查加斯氏病(美洲錐蟲病) 治療藥物市場, 全球市場, 臨床實驗 各地區 (%)
  • 查加斯氏病(美洲錐蟲病) 治療藥物市場, 全球市場, 臨床實驗 , 各國排名
  • 查加斯氏病(美洲錐蟲病) 治療藥物市場, 全球市場, 進行中的臨床實驗 , 各國排名
  • 查加斯氏病(美洲錐蟲病) 治療藥物的臨床實驗, 亞太地區, 主要國家 (%)
  • 查加斯氏病(美洲錐蟲病) (%)治療藥物的臨床實驗, 歐洲, 主要5個國家
  • 查加斯氏病(美洲錐蟲病) 治療藥物的臨床實驗, 北美, 主要國家 (%)
  • 查加斯氏病(美洲錐蟲病) 治療藥物的臨床實驗, 中南美, 主要國家 (%)
  • 查加斯氏病(美洲錐蟲病) 治療藥物的臨床實驗, 金磚四國 各國 (%)
  • 查加斯氏病(美洲錐蟲病) 治療藥物的臨床實驗, G7 各國 (%)
  • 查加斯氏病(美洲錐蟲病) 治療藥物市場, G7 各國, 臨床實驗 , 各臨床實驗狀態
  • 查加斯氏病(美洲錐蟲病) 治療藥物的臨床實驗, E7 各國 (%)
  • 查加斯氏病(美洲錐蟲病) 治療藥物市場, E7 各國, 臨床實驗 , 各臨床實驗狀態
  • 查加斯氏病(美洲錐蟲病) 治療藥物市場, 全球市場, 各階段臨床實驗 (%)
  • 查加斯氏病(美洲錐蟲病) 治療藥物市場, 全球市場, 進行中的臨床實驗 各階段
  • 查加斯氏病(美洲錐蟲病) 治療藥物市場, 全球市場, 臨床實驗 , 各臨床實驗狀態
  • 查加斯氏病(美洲錐蟲病) 治療藥物的臨床實驗, 全球市場, 平均登計對象人數趨勢
  • 查加斯氏病(美洲錐蟲病) 治療藥物的臨床實驗, 全球市場, 主要的贊助商
  • 查加斯氏病(美洲錐蟲病) 治療藥物的臨床實驗, 全球市場, 臨床實驗, 各有潛力治療藥
  • GlobalData 調查方法

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC2305CTIDB

GlobalData's clinical trial report, "Chagas Cardiomyopathy Global Clinical Trials Review, H2, 2014" provides data on the Chagas Cardiomyopathy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Chagas Cardiomyopathy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Chagas Cardiomyopathy. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Chagas Cardiomyopathy
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Chagas Cardiomyopathy to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Chagas Cardiomyopathy to Cardiovascular Clinical Trials
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Chagas Cardiomyopathy
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Drugs
  • Clinical Trial Overview of Top Institutes / Government
    • Universidade Federal de Minas Gerais
    • Clinical Trial Overview of Universidade Federal de Minas Gerais
    • Evandro Chagas Institute of Clinical Research
    • Clinical Trial Overview of Evandro Chagas Institute of Clinical Research
    • Ministerio da Saude, Brazil
    • Clinical Trial Overview of Ministerio da Saude, Brazil
    • Fundacion Cardiovascular de Colombia
    • Clinical Trial Overview of Fundacion Cardiovascular de Colombia
    • University Hospital Gottingen
    • Clinical Trial Overview of University Hospital Gottingen
    • Instituto do Coracao
    • Clinical Trial Overview of Instituto do Coracao
    • University of California, Los Angeles
    • Clinical Trial Overview of University of California, Los Angeles
    • The Hospital for Sick Children
    • Clinical Trial Overview of The Hospital for Sick Children
    • Johns Hopkins University
    • Clinical Trial Overview of Johns Hopkins University
    • National Heart, Lung, and Blood Institute
    • Clinical Trial Overview of National Heart, Lung, and Blood Institute
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Chagas Cardiomyopathy Therapeutics, Global, Clinical Trials by Region, 2014*
  • Chagas Cardiomyopathy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Chagas Cardiomyopathy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Chagas Cardiomyopathy Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Chagas Cardiomyopathy Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Chagas Cardiomyopathy Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Chagas Cardiomyopathy to Cardiovascular Clinical Trials, G7 Countries (%), 2014*
  • Chagas Cardiomyopathy Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Chagas Cardiomyopathy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Chagas Cardiomyopathy to Cardiovascular Clinical Trials, E7 Countries (%), 2014*
  • Chagas Cardiomyopathy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Chagas Cardiomyopathy Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Chagas Cardiomyopathy Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Chagas Cardiomyopathy Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Chagas Cardiomyopathy Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Chagas Cardiomyopathy Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Chagas Cardiomyopathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Chagas Cardiomyopathy Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Chagas Cardiomyopathy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Chagas Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Universidade Federal de Minas Gerais, 2014*
  • Chagas Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Evandro Chagas Institute of Clinical Research, 2014*
  • Chagas Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Ministerio da Saude, Brazil, 2014*
  • Chagas Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Fundacion Cardiovascular de Colombia, 2014*
  • Chagas Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Gottingen, 2014*
  • Chagas Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Instituto do Coracao, 2014*
  • Chagas Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Los Angeles, 2014*
  • Chagas Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by The Hospital for Sick Children, 2014*
  • Chagas Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2014*
  • Chagas Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014*

List of Figures

  • Chagas Cardiomyopathy Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Chagas Cardiomyopathy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Chagas Cardiomyopathy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Chagas Cardiomyopathy Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Chagas Cardiomyopathy Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Chagas Cardiomyopathy Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014*
  • Proportion of Chagas Cardiomyopathy to Cardiovascular Clinical Trials, G7 Countries (%), 2014*
  • Chagas Cardiomyopathy Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Chagas Cardiomyopathy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Chagas Cardiomyopathy to Cardiovascular Clinical Trials, E7 Countries (%), 2014*
  • Chagas Cardiomyopathy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Chagas Cardiomyopathy Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Chagas Cardiomyopathy Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Chagas Cardiomyopathy Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Chagas Cardiomyopathy Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Chagas Cardiomyopathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Chagas Cardiomyopathy Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Chagas Cardiomyopathy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top